For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk lung cancer — leaving nearly 70% of annual cancer cases and ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

Bipartisan legislation, supported by one local congressman, would provide Medicare coverage of multi-cancer early detection screening tests. The bill is called the Nancy Gardner Sewell Medicare ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in stage III and IV cancers.

We have a real-world evidence registry called Falcon, where we're enrolling up to 25,000 individuals who receive annual Cancerguard testing over three years. Our modeling studies suggest that if you ...

A scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for individuals with average risk for the disease reported finding ...